Delivery Order SPE2DR25D3103-SPE2DR26F9Y74
- Not listed
- On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $7,572.61 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick autoinjector pens. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation. The awardee, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a major pharmaceutical...
- The Defense Logistics Agency awarded a $9,080.88 firm fixed price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens. The award, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $10,541.01 delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injector pens. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.19 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens on December 19, 2025, with completion targeted for December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small but critical pharmaceutical procurement supporting military and federal healthcare needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $30,762.29 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens. The contract, awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this award. Repatha is a prescription medication used to...
- The Defense Logistics Agency awarded a delivery order valued at $3,870.15 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injector pens. This firm fixed-price delivery order, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, represents a non-set-aside, competitively awarded procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,648.59 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement, particularly for military and veteran healthcare systems. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $10,575.52 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens under a firm fixed price contract. The award was made on August 27, 2025, with an ultimate completion date of August 28, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $16,968.74 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector pens, with an ultimate completion date of November 4, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $31.2K to AmerisourceBergen Drug Corp on January 13, 2026, for the supply of Repatha 140 mg/mL SureClick auto-injector pens. The contract is competitively awarded with no set-aside designation and carries a firm fixed-price structure with an ultimate completion date of January 14, 2026. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9Y74Delivery Order
The Defense Logistics Agency awarded a $9,831.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injector pens on January 20, 2026, with completion targeted for January 21, 2026. This non-set-aside delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (which does business as AmerisourceBergen), is a major pharmaceutical distributor serving federal healthcare systems, particularly military and veteran populations. This delivery order is executed under Cencora, Inc.'s Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2031. The IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Repatha is a prescription medication used to treat high cholesterol, supporting the DLA's medical supply chain requirements for military treatment facilities and federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.8k | 1/19/26 |